Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graeff

Showing results (131-140 of 206) with videos related to

Pageof 21
Sort By:
Breast Cancer Research and Treatment|January 1, 1993
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerF Jänicke, M Schmitt, L Pache, et al.
Gynecologic Oncology|December 1, 1994
Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapyW Kuhn, L Pache, B Schmalfeldt, et al.
Geburtshilfe Und Frauenheilkunde|January 1, 1986
[Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer]R Schröck, R Hafter, L Schmid, et al.
International Journal of Oncology|October 17, 1998
Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)U Reuning, V Magdolen, O Wilhelm, et al.
Cancer Research|May 15, 1994
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1F Jänicke, L Pache, M Schmitt, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1981
[Prevention of deep-vein thrombosis in patients with gynaecological cancer undergoing radiotherapy. A comparison of calcium heparin and a semisynthetic heparin analogue (author's transl)]R von Hugo, R Hafter, K F Hiller, et al.
American Journal of Obstetrics and Gynecology|January 1, 1997
Angiogenin plasma levels during pregnancyM Kolben, J Bläser, K Ulm, et al.
Geburtshilfe Und Frauenheilkunde|June 1, 1991
[Clinic interns, individual performance appraisal and obstetric quality assurance]K T Schneider, W Oettle, E A Dumler, et al.
Thrombosis Research|April 1, 1988
The role of coagulation, fibrinogenolysis and fibrinolysis in the development of fluid and clotted cadaver plasmaW Klaubert, R Schönbauer, T Gilg, et al.
Gynakologische Rundschau|January 1, 1991
[Flow cytometry DNA analysis of pure cell nuclei from formalin fixed paraffin sections in primary breast cancer: correlation with other prognostic factors]N Harbeck, N Moniwa, E Busch, et al.
Pageof 21

Showing results (131-140 of 206) with videos related to

Sort By:
Pageof 21
Breast Cancer Research and Treatment|January 1, 1993
Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerF Jänicke, M Schmitt, L Pache, et al.
Gynecologic Oncology|December 1, 1994
Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapyW Kuhn, L Pache, B Schmalfeldt, et al.
Geburtshilfe Und Frauenheilkunde|January 1, 1986
[Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer]R Schröck, R Hafter, L Schmid, et al.
International Journal of Oncology|October 17, 1998
Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)U Reuning, V Magdolen, O Wilhelm, et al.
Cancer Research|May 15, 1994
Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1F Jänicke, L Pache, M Schmitt, et al.
Geburtshilfe Und Frauenheilkunde|March 1, 1981
[Prevention of deep-vein thrombosis in patients with gynaecological cancer undergoing radiotherapy. A comparison of calcium heparin and a semisynthetic heparin analogue (author's transl)]R von Hugo, R Hafter, K F Hiller, et al.
American Journal of Obstetrics and Gynecology|January 1, 1997
Angiogenin plasma levels during pregnancyM Kolben, J Bläser, K Ulm, et al.
Geburtshilfe Und Frauenheilkunde|June 1, 1991
[Clinic interns, individual performance appraisal and obstetric quality assurance]K T Schneider, W Oettle, E A Dumler, et al.
Thrombosis Research|April 1, 1988
The role of coagulation, fibrinogenolysis and fibrinolysis in the development of fluid and clotted cadaver plasmaW Klaubert, R Schönbauer, T Gilg, et al.
Gynakologische Rundschau|January 1, 1991
[Flow cytometry DNA analysis of pure cell nuclei from formalin fixed paraffin sections in primary breast cancer: correlation with other prognostic factors]N Harbeck, N Moniwa, E Busch, et al.
Pageof 21